FDA Clearance Tracker · K260343
Carescape Canvas 1000; Carescape Canvas Smart Display
Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 28, 2026
Substantially Equivalent
Time to decision
207 days
Received Feb 2, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K260343
- Device name
- Carescape Canvas 1000; Carescape Canvas Smart Display
- Applicant
- GE Healthcare Finland Oy
- Applicant location
- Helsinki, FI
- Received
- Feb 2, 2026
- Decided
- Aug 28, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1025
- Specialty
- CardiologyElectrophysiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MHX. The earliest in FDA's data is K872476, decided Sep 21, 1987.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260343
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for GE Healthcare Finland Oy
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260656 · Decided Sep 1, 2026 · 186 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
K223531 · Decided Apr 6, 2023 · 134 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
- CARESCAPE B650, E-musb510(k)
K213181 · Decided Apr 13, 2022 · 196 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.